Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-24 @ 11:08 PM
NCT ID:
NCT00704769
Eligibility Criteria:
Inclusion Criteria:
* Children patients of both sexes aged between 2-11 years, of either gender and any race
* Unequivocal history of perennial allergic rhinitis, including nasal congestion, sneezing, rhinorrhea, pruritus, and lacrimation
* Minimum score for inclusion: 10
* Capable of complying with the dosing regimen
* Free of any clinically significant disease (other than allergic rhinitis)
* Antihistamine must be justified by investigating doctor
Exclusion Criteria:
* Patients with asthma who require chronic use of inhaled or systemic corticosteroids
* History of frequent, clinically significant sinusitis or chronic purulent postnasal drip
* Patients with rhinitis medicamentosa
* History of hypersensitivity to desloratadine or any of its excipients
* Doctor deems unsuitable
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
11 Years
Study:
NCT00704769
Study Brief:
Protocol Section:
NCT00704769